Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Olanzapine-Associated Weight Gain
NCT00401973Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of amantadine, liquid metformin (Aspargo Labs), zonisamide, sponsored by Eli Lilly and Company. Started Nov 2006; status: completed.
02
Drugs
amantadineliquid metformin (Aspargo Labs)zonisamide
Beyond the preview
Go deeper on NCT00401973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401973.